Annexin Pharmaceuticals Ab Publ
Annexin Pharmaceuticals is a biotechnology company focused on Annexin A5 for treating cardiovascular diseases.
- Headquarters
- Stockholm, Stockholm County, SwedenSource: RevenueBaseRetrieved October 13, 2026
- Employee range
- 1 to 10Source: RevenueBaseRetrieved October 13, 2026
- Founded
- 2014Source: RevenueBaseRetrieved October 13, 2026
- Published list appearances
- 3 supported appearances ↗Source: RevenueBase lists
What does Annexin Pharmaceuticals Ab Publ do?
Its biological drug candidate ANXV is intended primarily for acute treatment of patients with cardiovascular diseases involving vascular damage and inflammation. The company has established and optimized a cell line for large-scale Annexin A5 production, and its production process is patented.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Company lists.
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Share your recognition
Embeddable award for your website
Sources & data notes.
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 6, 2026, September 14, 2026 and October 8, 2026. How the company lists are built.
Something changed?
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
One company is just the start.
Explore more companies by name, headquarters and business focus.